Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397781 · ClinicalTrials.gov registry record · Phase 4
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
A Phase 4 study, sponsored by Boston Children's Hospital.
- Not yet
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT06397781: Clinical Trial Phase 4 study, sponsored by Boston Children's Hospital.
NCT06397781 is a Phase 4 study that has not yet begun recruiting, run by Boston Children's Hospital. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397781, a Phase 4 study, has not yet begun recruiting, sponsored by Boston Children's Hospital.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Our hypothesis is that S. aureus skin decolonization in atopic dermatitis reduces disease severity and favorably alters the function and gene expression of epidermal and immune skin cells that contribute to disease severity.
Primary Outcome
severity index
Interventions
- DRUG Skin Cleanser Combination No.1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2031-01-01 |
| Est. Completion | 2039-12 |
| Phase | Phase 4 |
What is known before NCT06397781 opens enrollment
NCT06397781 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Skin Cleanser Combination No.1 is the first listed.
NCT06397781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06397781 about?
NCT06397781 is a clinical study titled "Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients". Our hypothesis is that S. aureus skin decolonization in atopic dermatitis reduces disease severity and favorably alters the function and gene expression of epidermal and immune skin cells that contribute to disease severity.
What is the current status of trial NCT06397781?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2031-01-01. Estimated completion is 2039-12.
What interventions are being tested in trial NCT06397781?
The interventions under investigation include: Skin Cleanser Combination No.1 (DRUG).
Who is sponsoring clinical trial NCT06397781?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06397781's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI